Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Nortran's anesthetic RSD-921 nears phase II trials in Malaysia

April 16, 1998

NeuroSearch receives FDA approval to begin phase II trial with NS-2710

April 16, 1998

CRF antagonists for stress-related disorders from DuPont Merck

April 16, 1998

New class of adenosine antagonists prepared at Boehringer Ingelheim

April 16, 1998

Kappa agonists developed at Warner-Lambert

April 15, 1998

Anticonvulsant drugs: a new treatment alternative for psychiatric disorders

April 15, 1998

Radical-scavenging furan nitrone compounds in the pipeline at Centaur

April 14, 1998

Adenosine antagonists for CNS, cardiovascular and other disorders

April 14, 1998

Interneuron receives fast track designation for CerAxon

April 9, 1998

MS&D describes novel class of antimigraine agents

April 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...